πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 338 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12427137

Method for reducing methane production in animal stomach

China Agricultural University Β· Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12421269

SGLT2/DPP4 inhibitor and application thereof

CGeneTech (Suzhou, China) CO., Ltd. Β· Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12403167

Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation method thereof

OCEAN UNIVERSITY OF CHINA Β· Granted Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12397034

Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesi

China Medical University Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12389931

Oyster peptide with effect of improving sexual function and preparation method thereof

CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12383535

Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method ther

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12378241

Pyridine derivative as FGFR and VEGFR dual inhibitors

CGeneTech (Suzhou, China) CO., Ltd. Β· Granted Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12371434

MLL1 inhibitors and anti-cancer agents

CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH CO., LTD. Β· Granted Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12364671

Methods of administering vitamin A and lactic acid to gilts

China Agricultural University Β· Granted Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12358863

Nitrogen-containing derivative of substituted phenol hydroxy acid ester, and preparation a

WEST CHINA HOSPITAL, SICHUAN UNIVERSITY Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12357666

Traditional Chinese herbal plant composition for improving symptoms of liver cancer patien

The First Hospital of China Medical University Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12350270

Antimalarial agents

MSD R&D (China) Co. Ltd. Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12343448

Use of stem cells produced by stem cell generator in treatment of hematopoietic damage

East China University of Science and Technology Β· Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12343321

Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on repr

China Agricultural University Β· Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12338219

Antimalarial agents

MSD R&D (China) Co. Ltd. Β· Granted Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12331058

SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12324798

Leonurine nanocomposite hydrogel and preparation methods and applications thereof

WEST CHINA HOSPITAL, SICHUAN UNIVERSITY Β· Granted Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12325703

Fused ring compound as FGFR and VEGFR dual inhibitor

CGeneTech (Suzhou, China) CO., Ltd. Β· Granted Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12319729

Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, a

China Medical University Hospital Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12310944

Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, pre

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12297300

Hyaluronic acid-based zwitterionic polymer brush, preparation method thereof, and use ther

South China University of Technology Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12291530

GLP-1R agonist and therapeutic method thereof

Ascletis Pharma (China) Co., Limited Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12281164

Genetically engineered dual-targeting chimeric antigen receptor and use thereof

WEST CHINA HOSPITAL, SICHUAN UNIVERSITY Β· Granted Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12269808

Amino dithioperacid thioester compound, preparation method therefor, and use thereof

EAST CHINA NORMAL UNIVERSITY Β· Granted Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted